Amgen Inc (NASDAQ:AMGN)

147.26
Data as of Oct 24
 +0.01 / +0.01%
Today’s Change
108.20
Today|||52-Week Range
148.14
+29.08%
Year-to-Date
Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog
Oct 24 / Zacks.com
Market Wrap: Existing Sales Outpace in Sept.; Loeb's Third Point Eyes Amgen; Daimler ...
Oct 21 / Investing Channel
Top 10 News for 10/20 - 10/24: Apple Ramps on Results; Loeb Eyes Amgen; Advanced Tech...
Oct 24 / Investing Channel
Loeb urges Amgen to explore a break-up
Oct 21 / FT.com
3 Money-Making Biotech Stocks That Could Go Higher
Oct 24 / MotleyFool.com
Notable 52-Week Highs and Lows of the Day 10/21: (AKRX) (AMGN) (CCI) High; (OCN) (BBC...
Oct 21 / Investing Channel
Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog
Oct 23 / Zacks.com
Third Point's Notable Additions And Exit: Alibaba, eBay, Sony
Oct 21 / Benzinga
Fast Money Picks For October 23
Oct 23 / Benzinga
One Reason eBay (EBAY) Stock Is Up Today
Oct 21 / TheStreet.com
Drug ETFs Attractive Buys On Pullback
Oct 22 / Benzinga
Why Amgen (AMGN) Stock Is Rising in Afternoon Trading Today
Oct 21 / TheStreet.com
Stock Market Today: Markets Tumble Into Close on Oil Inventory, Canadian Shooting
Oct 22 / TheStreet.com
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog
Oct 20 / Zacks.com
The Complete Robin Hood Conference Summary
Oct 22 / Investing Channel
Stocks To Watch For October 20, 2014
Oct 20 / Benzinga
Amgen Gains as Third Point Suggests Split - Analyst Blog
Oct 22 / Zacks.com
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo ...
Oct 15 / Zacks.com
Despite Stock Market Rally Many Opportunities Still Exist
Oct 22 / TheStreet.com
A Quick Look at Amgen, Inc.'s Drug Development Pipeline
Oct 15 / MotleyFool.com
3 Stocks Pulling The Drugs Industry Downward
Oct 22 / TheStreet.com
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Oct 14 / MotleyFool.com
Wednesday Links:
Oct 22 / StockTwits
Where Will Celgene Corporation Stock Be a Year From Now?
Oct 14 / MotleyFool.com
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breaku...
Oct 22 / Zacks.com
3 Dividend Stocks to Buy If the Market Crashes
Oct 14 / MotleyFool.com
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
Oct 22 / TheStreet.com
Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog
Oct 13 / Zacks.com
Amgen: splitting hairs
Oct 22 / FT.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog
Oct 13 / Zacks.com
Celgene Corporation's Earnings Preview: Pay Attention to New Kids
Oct 22 / MotleyFool.com
3 Companies With the Best Retirement Plans
Oct 12 / MotleyFool.com
October 22 Premarket Briefing: 10 Things You Should Know
Oct 22 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.